Traumatic Stress among School-Aged Pediatric Surgery Patients and Their Parents

Amichai Ben Ari1, Daniella Margalit1, Raphael Udassin2

  • 1Department of Behavioral Sciences, Ariel University, Ariel, Israel.

Insights

Pediatric Medical Traumatic Stress (PMTS) affects over a quarter of children post-surgery, with many parents also experiencing distress. Early identification and intervention are crucial for managing this condition.

Area of Science:

  • Pediatric Surgery
  • Child Psychology
  • Trauma Studies

Background:

  • Hospitalization can be traumatic for children, leading to Pediatric Medical Traumatic Stress (PMTS).
  • PMTS causes significant distress and functional impairment, yet awareness and prevention efforts are lacking.
  • This study addresses the gap in understanding PMTS prevalence in school-aged children post-pediatric surgery.

Purpose of the Study:

  • To prospectively assess the prevalence and characteristics of PMTS in school-aged children after hospitalization.
  • To evaluate the occurrence of PMTS symptoms in parents of these children.
  • To document the psychological impact of pediatric surgery on children and their families.

Main Methods:

  • Recruited parents of 88 children (aged 6-13) hospitalized in a pediatric surgery ward.
  • Administered questionnaires to parents 3-5 months post-discharge to assess psychological distress.
  • Focused on a representative sample to ensure generalizability of findings.

Main Results:

  • 26.4% of children exhibited symptoms of Pediatric Medical Traumatic Stress.
  • 11.6% of parents reported symptoms consistent with posttraumatic stress disorder.
  • A significant positive correlation was observed between parental and child distress levels.

Conclusions:

  • The prevalence of PMTS in school-aged children post-surgery necessitates greater attention.
  • Increased awareness, preventive strategies, and early treatment are vital for mitigating PMTS.
  • Addressing parental distress is also important for comprehensive care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
569
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
240
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305